Dr. Faith Davies earned her medical degree from the University of Wales College of Medicine and completed her general medical training and hematology specialty training in the United Kingdom. She then held positions with the Institute of Cancer Research and the Royal Marsden Hospital, both in London, prior to moving to the USA. Dr. Davies is a Professor of Medicine and Deputy Director of the Myeloma Institute at the University of Arkansas for Medical Sciences in Little Rock, Arkansas.

Dr. Davies is a member of the American Society of Hematology, the American Association for Cancer Research, the Royal College of Physicians (UK), and the Royal College of Pathologists (UK). She is widely published in The New England Journal of Medicine, Blood, Journal of Clinical Oncology, Leukemia, and The Lancet Oncology, among others. Her clinical research focuses on the treatment of multiple myeloma, particularly the investigation of new drugs and genetic technologies to improve patient outcomes. Her laboratory work is aimed at identifying biologically based therapeutic targets in myeloma that are amenable to small-molecule interventions and translating those laboratory findings into the clinical arena to provide individualized treatment.